How To Creat Website
How To Creat Website
F.No.01.101/2017-PCI
The minutes of 01.101st meeting of the Central Council of the Pharmacy Council of India
held on 6th & 7th April, 2017 at Ooty.
=====================================================================
* Consideration of approval of the Diploma, Degree, Pharm.D and Pharm.D (Post Baccalaureate),
M.Pharm and B.Pharm (Practice) course and examination in Pharmacy.
-----------------------------------------------------------------------------------------------------------------------------
The following resolutions moved by Shri M. Venkata Reddy, Shri Ajay Singh Rajput and Sri Ajay Phatak
and seconded by Shri H.G. Koshia, Shri Neeraj Upmanyu and Shri Sunil Kumar Chaudhary were
unanimously passed applicable in respect of all approvals u/s 12 of the Pharmacy Act, 1948 for the
purpose of registration as a pharmacist.
A. Fortheapprovalu/s12
"(1) In pursuance of the provisions of sub section (1) of section 12 of the Pharmacy Act, 1948 (8 of
1948), the Pharmacy Council of India declares the course in Pharmacy (as applicable)
conducted by institutions mentioned below to be an approved course of study for the purpose
of admission to an approved examination in Pharmacy (as applicable) in respect of number of
students and academic session as specified here under:
(2) In pursuance of the provisions of sub-section (2) of section 12 of the Pharmacy Act, 1948 (8 of
1948), the Pharmacy Council of India declares the Examination in Pharmacy (as applicable)
held by the Examining Authorities mentioned against their name, during the session mentioned
to be an approved examination for the purpose of qualifying for registration as a Pharmacist
under the said Act.”
B. Theapprovalissubjectto -
a) the institution shall submit SIF every year as per the Time-Schedule prescribed by the Council.
b) the institution shall submit annual affiliation fee on or before due date.
c) the institution shall appoint the teaching faculty with the qualification and experience as
prescribed under the “Minimum Qualification for Teachers in Pharmacy Institutions Regulations,
2014”.
C. Besides above conditions, institutions seeking approval of Pharm.D / Pharm.D (Post Baccalaureate)
course shall comply with the following conditions -
1. The institution shall comply with the requirements of Pharm.D. Regulations, 2008 particularly
regarding appointment of teaching staff, equipments and Hospital facility.
2. Further the PCI recommends that Pharmacy Practice Faculty including HOD shall undergo at
least 1 Continuing Education Programme / Training Programme of minimum 3 days duration
every year and participation in atleast one seminar/conference every year.
3. In view of above, it was decided to ask the institutions concerned to intimate the council per
return of mail the number of such Continuing Education Programmes / Training Programmes /
Seminar / Conference etc. attended by HOD and pharmacy practice faculty during the last one
year with documentary evidence i.e. participation certificate etc.
4. The institution to submit full compliance of the Pharm.D Regulations, 2008 as per following
details:-
TrainingofHODofPharmacyPracticeDepartmentandPharmacyPracticeFaculty
The HOD & the faculty of Pharmacy Practice Department who are not qualified with M.Pharm
Pharmacy Practice Qualification or Pharm.D Qualification and have other specialized training of
F 22
qualification in the Pharmacy Practice Department, shall undergo the training as per Regulations
3 vi) of Appendix–B of Pharm.D Regulations, 2008. The following details be submitted –
i) In respect of HOD of Pharmacy Practice ii) In respect of Pharmacy Practice Faculty of
Department Pharmacy Practice Department
a) Name of HOD a) Name of Pharmacy Practice Staff
b) Designation b) Designation
c) Qualification at graduate level c) Qualification at graduate level
d) Qualification at PG level with specialization d) Qualification at PG level with specialization
e) Name of Training Centre e) Name of Training Centre
f) Duration of Training f) Duration of Training
g) Nature of Training g) Nature of Training
h) Sign of Principal h) Sign of HOD
5. The institution shall upload the details of students of Pharm.D./ Pharm.D (Post Baccalaureate)
course separately as applicable on Council’s website and the institutions website, year wise
giving the following details –
a) Name of the Institution :
b) Name of the affiliating university :
c) Name of the hospital where the :
clerkship and internship is done
S.No. Name of Father’s Name Date of Course : Year of University Year of
Student Birth Pharm.D/ admission Registration Passing
Pharm.D No.
(PB)
D. RegardingM.Pharmcourse -
"(1) In pursuance of the provisions of sub section (1) of section 12 of the Pharmacy Act, 1948 (8 of
1948), the Pharmacy Council of India declares the running of M.Pharm course in mentioned
specializations conducted by institution/s to be an approved “course of study” for the purpose
of admission to an examination for M.Pharm course in respect of mentioned specializations,
number of students and academic session as specified.
(2) Further as required under regulation 6 of Appendix-B of “The Master of Pharmacy (M.Pharm)
Course Regulations, 2014”, the Examining Authority and institution shall communicate to the
PCI, not less than six weeks in advance the dates fixed for examinations, the time-table for such
examinations, so as to enable the Council to arrange for inspection to attend at such
examinations.”
F 33
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 44
Otherdecision
- Regarding Clinical Pharmacy & Quality Assurance Techniques, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
- The recommendations of EC were reviewed and above decision was taken.
10.2 It was decided to approve the change in the name of Examining Authority as per
following details -
From To
Rajasthan University Health The Registrar
Sciences, Kumbha Marg, Geetanjali University
Sector-17 Udaipur (Rajasthan).
Pratap Nagar Tonk Road
Jaipur – 302 003.
4. Pharmacology 10
5. Pharmacognosy 10
4. Pharmacology 15
5. Hospital & 15
Clinical Pharmacy
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Hospital & Clinical
Pharmacy, it was noted that the nomenclature is not as per Appendix-A of M.Pharm Regulations,
hence institution shall justify the nomenclature with course content for consideration of approval
under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
F 99
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
F 101
0
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutical Management &
Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration of
approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature is
not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 161
6
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
5. Quality Assurance 9
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
4. Pharmacology 8
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 222
2
Otherdecision
- Regarding Pharmaceutical Analysis and Quality Assurance, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 242
4
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis and Quality Assurance, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 262
6
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
5. Pharmacology 15
Otherdecision
- Regarding Pharmaceutical Management & Regulatory Affairs, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
5. Pharmacology 9
Otherdecision
- Regarding Pharmaceutical Management & Regulatory Affairs, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
F 292
9
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 303
0
Otherdecision
- It was further decided to inspect the institution deputing one PCI member with inspection team for
considering further extension of approval.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature is
not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutics and Pharmaceutical Technology, it was noted that experience of
teaching staff is not as prescribed under “The Master of Pharmacy (M.Pharm) Course Regulations,
2014” and “Minimum Qualification for Teachers in Pharmacy Institutions Regulations, 2014”.
F 333
3
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 353
5
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutical
Management & Regulatory Affairs, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature is
not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 363
6
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
5. Pharmacognosy 4
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 373
7
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
5. Pharmacology 15
F 383
8
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 404
0
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 414
1
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
F 424
2
Otherdecision
- The recommendations of EC were reviewed and above decision was taken.
F 444
4
5. Regulatory 15
Affairs
6. Pharmacology 15
7. Pharmaceutical 9
Analysis
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 474
7
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutical Management
& Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration
of approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
5. Pharmacology 15
6. Pharmacognosy 10
Otherdecision
- Regarding Pharmacy Practice (Clinical Pharmacy), it was noted that the nomenclature is not
as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with
course content for consideration of approval under Appendix-A of M.Pharm Regulations or align
the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
5. Pharmacology 15
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutics & Drug
Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration
of approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
F 505
0
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
5. Pharmacognosy 15
6. Pharmacy Practice 9
F 545
4
Otherdecision
- Regarding Pharmaceutical Analysis and Quality Assurance, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
Otherdecision
- Regarding Industrial Pharmacy, it was decided not to approve this specialization as no requisite
teaching staff is available as per “The Master of Pharmacy (M.Pharm) Course Regulations, 2014”
and “Minimum Qualification for Teachers in Pharmacy Institutions Regulations, 2014”.
F 555
5
5. Pharmacology 12
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- It was further decided to approve the change in the name of Examining Authority w.e.f. 4.3.2016 as
per following details -
From To
Punjab Technical University, Maharaja Ranjit Singh Punjab
REC Campus, Amritsar Technical University,
Byepass, G.T. Road, Bathinda (erstwhile Maharaja
Ladowali Road, Ranjit Singh State Technical
Jalandhar – 144 001(Punjab) University, Bathinda)
F 565
6
5. Pharmacology 9
6. Pharmacognosy 12
Otherdecision
- Regarding Quality Assurance and Pharmaceutical Management & Regulatory Affairs, it was
noted that the nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution
shall justify the nomenclature with course content for consideration of approval under Appendix-A
of M.Pharm Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 575
7
Otherdecision
- Regarding Pharmaceutical Analysis and Quality Assurance, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 585
8
Otherdecision
- Regarding Pharmaceutical Quality Techniques, it was noted that the nomenclature is not as
per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with
course content for consideration of approval under Appendix-A of M.Pharm Regulations or align
the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
5. Pharmacology 6
6. Pharmacognosy 10
F 626
2
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
F 656
5
5. Quality Assurance 9
6. Pharmacology 12
7. Pharmacognosy 6
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 666
6
Otherdecision
- Regarding Clinical Pharmacy, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 676
7
Otherdecision
- Regarding Pharmaceutical Management & Drug Regulatory Affairs, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 686
8
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 707
0
Otherdecision
- Regarding Pharmaceutics, it was noted that teaching staff details are not indicated. In view of it,
it was decided to seek the details of teaching staff with documentary evidence.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 737
3
6. Pharmaceutical 9
Analysis
7. Pharmacology 15
8. Pharmacy Practice 15
9. Pharmacognosy 9
Otherdecision
- Regarding Drug Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-
A of M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 757
5
4. Pharmaceutical 6
Management &
Regulatory
Affairs
Otherdecision
- Regarding Pharmacology, it was noted that teaching staff details are not indicated. In view of it,
it was decided to seek the details of teaching staff with documentary evidence.
- Regarding Pharmaceutical Management & Regulatory Affairs, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
F 767
6
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutical Management
& Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration
of approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 777
7
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 787
8
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
214.2 It was noted that the following specializations are already approved –
1. Pharmaceutics for 12 admissions.
2. Pharmacology for 12 admissions.
214.3 It was noted that 274th EC (Feb., 2017) recommended approval. The institution
submitted representation, considering which the decision of 274th EC (Feb., 2017) was
reiterated as above.
5. Pharmacognosy 3
Otherdecision
- Regarding Pharmacy Practice, it was noted that experience of teaching staff is not indicated. In
view of it, it was further decided to seek the details of the same with documentary evidence.
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 818
1
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmacy Practice & Clinical Pharmacy and Pharmaceutical Analysis & Quality
Assurance, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration
of approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
F 828
2
Otherdecision
- Regarding Pharmaceutical Management & Regulatory Affairs, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
F 838
3
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 858
5
4. Pharmacology 12
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 868
6
4. Pharmacy Practice 10
5. Pharmacology 12
F 878
7
5. Pharmaceutical 6
Management &
Regulatory
Affairs
Otherdecision
- Regarding Pharmacology, it was noted that teaching staff details are not indicated. In view of it,
it was decided to seek the details of teaching staff with documentary evidence.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 898
9
Otherdecision
- Regarding Pharmacology, it was noted that teaching staff details are not indicated. In view of it,
it was decided to seek the details of teaching staff with documentary evidence.
Otherdecision
- Regarding Pharmacy Practice, it was noted that teaching staff details are not indicated. In view
of it, it was decided to seek the details of teaching staff with documentary evidence.
F 919
1
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutical Management
& Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration
of approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutical Management &
Regulatory Affairs and Hospital & Clinical Pharmacy, it was noted that the nomenclature is not
as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with
course content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 949
4
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 959
5
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 979
7
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 989
8
5. Pharmaceutical 9
Regulatory
Affairs
6. Pharmaceutical 9
Analysis
Otherdecision
- Regarding Pharmaceutical Regulatory Affairs, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 999
9
4. Pharmacology 9
4. Pharmacology 6
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 100
100
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 101
101
5. Pharmacognosy 8
6. Pharmaceutical 10
Technology
7. Pharmacology 10
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- Regarding Pharmaceutical Analysis, it was noted that teaching staff was absent. In view of it, it
was decided to seek the details of teaching staff with documentary evidence.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
4. Pharmacy 15
Practice / Clinical
Pharmacy
5. Pharmacology 12
Otherdecision
- Regarding Pharmaceutical Management & Regulatory Affairs and Pharmacy Practice /
Clinical Pharmacy, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration
of approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
F 104
104
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutical Management &
Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration of
approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
F 105
105
5. Pharmacology 12
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Control, it was noted that the nomenclature is
not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
4. Pharmaceutical 9
Analysis
5. Pharmaceutical 15
Quality Assurance
6. Pharmaceutical 15
Regulatory
Affairs
7. Pharmacy Practice 15
8. Pharmacology 15
9. Pharmacognosy 6
10. Cosmeceutics 3
Otherdecision
- Regarding Cosmeceutics and Pharmaceutical Regulatory Affairs, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
F 107
107
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that experience of
teaching staff is not as prescribed. Hence, it was decided to seek the compliance of same.
Otherdecision
- Regarding Pharm.D. (PB) course, it was decided to seek the consent of affiliation of Examining
Authority for Pharm.D. (PB).
4. Pharmacy 15
Practice
5. Pharmacology 15
Otherdecision
- Regarding Pharmaceutical Management & Regulatory Affairs, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
F 110
110
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
4. Pharmacognosy 9
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the decision of 274th EC (Feb., 2017) was reiterated as above.
F 111
111
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 112
112
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
5. Pharmacy Practice 10
6. Pharmacology 8
F 114
114
4. Pharmacognosy 12
Otherdecision
- Regarding Pharmacology and Texicology, it was noted that -
a) experience of teaching staff is not as prescribed under “The Master of Pharmacy (M.Pharm)
Course Regulations, 2014” and “Minimum Qualification for Teachers in Pharmacy
Institutions Regulations, 2014”.
b) the nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall
justify the nomenclature with course content for consideration of approval under Appendix-A
of M.Pharm Regulations or align the nomenclature with prescribed nomenclatures under
M.Pharm Regulations.
F 115
115
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- Regarding Pharmaceutics, it was noted that the teaching staff as per “The Master of Pharmacy
(M.Pharm) Course Regulations, 2014” and “Minimum Qualification for Teachers in Pharmacy
Institutions Regulations, 2014” is not appointed.
Otherdecision
4. Pharmaceutical 15
Analysis
5. Pharmaceutics 9
Quality Assurance
6. Pharmaceutical 9
Regulatory
Affairs
7. Pharmaceutical 6
Biotechnology
8. Pharmacy Practice 15
9. Pharmacology 15
10.Pharmacognosy 15
Otherdecision
- Regarding Pharmaceutical Regulatory Affairs, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 118
118
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 120
120
4. Pharmacology 6
5. Pharmacognosy 12
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
4. Pharmacognosy 3
F 121
121
Otherdecision
- Regarding Pharmacognosy, it was noted that the teaching staff as per “The Master of Pharmacy
(M.Pharm) Course Regulations, 2014” and “Minimum Qualification for Teachers in Pharmacy
Institutions Regulations, 2014” is not appointed.
Otherdecision
- Regarding Pharmaceutics Drug Regulatory Affairs, it was noted that the nomenclature is not
as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with
course content for consideration of approval under Appendix-A of M.Pharm Regulations or align
the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Hospital & Clinical
Pharmacy, it was noted that the nomenclature is not as per Appendix-A of M.Pharm Regulations,
hence institution shall justify the nomenclature with course content for consideration of approval
under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
F 123
123
01.101.330: Issue – Signing of MOU between Ministry of Health & Family Welfare with
Ministry of Skill Development and Entrepreneurship on 11.7.2015 to conduct
Skill Training Programmes for “Pharmacy Assistants for preferably class XII in
Science” with the following training outcomes –
Understand the principles and fundamentals of pharmacology and their
application.
Receive prescription from pharmacist and verify that information is complete.
Record and select the correct medicines for dispensing.
Establish or maintain patient profile, including lists of medications taken by
individual patients.
Manage and maintain the drugs supply and order.
Dispense medications according to the prescription.
Page Maintain proper storage and security condition for drugs.
No.4013
Manage inventory of medicines and equipments.
Maintain a safe, healthy, and secure working environment.
---------------------------------------------------------------------------------------------------
(2-26/2016-PCI)
330.2 It was noted that the draft Model Curriculum for Pharmacy Assistant as presented by the
Health Care Sector Skill Council indicates that the training outcomes will be as under :- a)
to understand the principles and fundamentals of pharmacology and their application. b)
to record and select the correct medicines for dispensing.
c) to establish or maintain patient profile, including lists of medications taken by
individual patients.
d) to manage and maintain the drugs supply and order.
e) to maintain proper storage and security condition for drugs.
f) to manage inventory of medicines and equipments.
g) to maintain a safe, healthy, and secure working environment.
330.3 The matter was discussed in great detail. It was decided to intimate to the Ministry that -
a) the topics and contents of the proposed Pharmacy Assistant course are already
covered in the course curriculum of diploma course in pharmacy.
b) under the Pharmacy Act, 1948 and the regulations framed thereunder, the minimum
qualification for registration as a pharmacist to practice under the Pharmacy Act,
1948 is diploma course in pharmacy which is a 2 years course followed by 500 hours
of practical training after 10+2 science academic stream (regular course).
c) the following expected key outcomes of the proposed Pharmacy Assistant course can
only be performed by a registered pharmacist as per section 42 of the Pharmacy Act,
1948 and Pharmacy Practice Regulations, 2015 duly approved by the Govt. of India -
i) to receive a prescription and verify that information is complete.
ii) to dispense medications according to the prescription.
d) dispensing of medicines by a person other than a registered pharmacist / medical
practitioner for his own patients is a cognizable offense under the Pharmacy Act,
1948.
e) further the following expected key outcomes of the proposed Pharmacy Assistant
course are already being performed by the registered pharmacist -
to understand the principles and fundamentals of pharmacology and their
application.
to record and select the correct medicines for dispensing.
to establish or maintain patient profile, including lists of medications taken by
individual patients.
to manage and maintain the drugs supply and order.
to maintain proper storage and security condition for drugs.
to manage inventory of medicines and equipments.
to maintain a safe, healthy, and secure working environment.
f) the registered pharmacist is under oath to maintain the confidentiality of the identity
of the patient. Personal health information of a patient cannot be allowed to be shared
with any one including Pharmacy Assistant unless compelled to do so by law.
g) there is sufficient pharmacy manpower available in the country. The intake capacity
of pharmacy institutions in various pharmacy courses is approx. 1.36 lakhs per
annum. At present there are approx. 7.5 lakhs registered pharmacists in the country.
h) the proposed cadre of Pharmacy Assistant will not be eligible for registration as a
pharmacist under the Pharmacy Act to practice the pharmacy profession.
F 127
127
352.2 The following decision was taken. The approval wherever granted is subject to final
outcome of inspection.
S.No./F.No. College Specialization No. of Remarks
approved by PCI admns.
approved
1/ Sri Ramachandra 1. Pharmaceutics 15 1. Regarding Quality Assurance,
60-140/16 College of Pharmacy, it was noted that the
nomenclature is not as per
Sri Ramachandra 2. Quality Assurance 15 Appendix-A of M.Pharm
University, 1, Regulations, hence institution
Ramachandra Nagar, 3. Pharmaceutical 15 shall justify the nomenclature
Porur, Chemistry with course content for
consideration of approval
Chennai – 600 116 under Appendix-A of
Tamil Nadu. 4. Pharmaceutical 15 M.Pharm Regulations or align
Analysis the nomenclature with
prescribed nomenclatures
under M.Pharm Regulations.
5. Pharmacognosy 15
6. Pharmacology 15
7. Pharmacy Practice 15
F 128
128
5. Pharmacology 3
6. Pharmaceutical 6
Chemistry
6/ Department of Pharmaceutics 6
60-1133/16 Pharmacy, Mewar
University, Gangrar,
Chittorgarh Rajasthan.
5. Quality Assurance 15
Techniques
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 274th EC (Feb., 2017) recommended approval. The recommendations were
reviewed and above decision was taken subject to verification of additional faculty.
01.101.358: A. Reporting on present status of institutions applied for M.Pharm for 2016-2017
academic session.
B. Duration of M.Pharm approval.
---------------------------------------------------------------------------------------------------
(60-Main new application for 2016-2017-PCI)
01.101.359: Reporting on Bridge course application received from institution wise during
2016-2017 academic session.
---------------------------------------------------------------------------------------------------
(70-Bachelor of Pharmacy (Practice) course Applications for 2016-2017 (Main))
359.2 Noted.
Otherdecision
- Regarding Biopharmaceutics, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 134
134
6. Pharmaceutical 6
Biotechnology
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmacognosy & Phyto-chemistry, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 138
138
44 admitted in
2009-2010
admitted in
19
2010-2011
57 admitted in
2011-2012
11 admitted in
2012-2013
Otherdecision
- Regarding students admitted in 2013-2014 & 2014-2015 academic session, it was further decided to
inspect the institution to check the facts whether students admitted in 2013-2014 & 2014-2015 are
still studying in 3rd year and 4th year.
F 139
139
Otherdecision
- Regarding M.Pharm (Pharmacy), it was noted that the nomenclature is not as per Appendix-A
of M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- It was further decided to seek details of infrastructure and teaching staff for the same for further
consideration.
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
Otherdecision
- Regarding Pharmaceutics / Pharmaceutical Technology, it was noted that the nomenclature is
not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 140
140
Otherdecision
- It was further decided to instruct the institution –
a) to submit compliance of deficiencies pointed out in the inspection report with documentary
evidence.
b) to appoint teaching staff immediately as prescribed under “The Bachelor of Pharmacy
(B.Pharm) Course Regulations, 2014” and “Minimum Qualification for Teachers in Pharmacy
Institutions Regulations, 2014” for considering further extension of approval.
F 142
142
Otherdecision
- Regarding Pharmaceutical Technology and Pharmaceutical Analysis, it was noted that
experience of teaching staff is not as prescribed under “The Master of Pharmacy (M.Pharm)
Course Regulations, 2014” and “Minimum Qualification for Teachers in Pharmacy Institutions
Regulations, 2014”.
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 143
143
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- It was noted that 274th EC (Feb., 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
5. Pharmacology 12
6. Pharmacognosy 15
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 147
147
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
4. Pharmacology 12
5. Pharmaceutical 15
Analysis
4. Pharmacology 15
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- It was further decided to inspect the institution.
- It was also decided to approve the change of the Examining Authority in respect of D.Pharm,
B.Pharm & M.Pharm course as per following details -
From To
The Registrar The Registrar
Rajiv Gandhi Proudyogiki Dr. A.P.J. Abdul Kalam
Vishwavidyalaya, University
Airport, Byepass Road, Indore-Dewas Bypass,
Gandhi Nagar, Arandia
Bhopal –462036 Indore-452016
(MadhyaPradesh). MadhyaPradesh
Otherdecision
- It was further decided to inspect the institution for considering extension of approval.
F 151
151
Otherdecision
- Regarding Drug Regulatory Affairs, it was noted that -
a) experience of teaching staff is not as prescribed under “The Master of Pharmacy (M.Pharm)
Course Regulations, 2014” and “Minimum Qualification for Teachers in Pharmacy
Institutions Regulations, 2014”.
b) the nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall
justify the nomenclature with course content for consideration of approval under Appendix-A
of M.Pharm Regulations or align the nomenclature with prescribed nomenclatures under
M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis, it was noted that other teaching staff was absent on the
other day of inspection.
F 153
153
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
4. Pharmacy Practice 10
5. Pharmacology 12
6. Pharmacognosy 10
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
01.101.445: Approval of the Diploma course in respect of three students of 1993-94 batch
conducted at D.Pharm Course at Arundhanthi College of Pharmacy, Bangalore
(Karnataka).
---------------------------------------------------------------------------------------------------
(17-522/97-PCI)
445.1 The latest information on record was placed.
445.2 It was noted that Examining Authority has submitted the D.Pharm pass certificates in
respect of following 3 students admitted during 1993-94 batch -
1. Shri Anandaraju K H
2. Smt. Kirana Kumari K
3. Shri Ravi Raj B S
445.3 In view of above, it was decided to grant approval in respect of the following 3 students
admitted during 1993-94 batch -
1. Shri Anandaraju K H
2. Smt. Kirana Kumari K
3. Shri Ravi Raj B S
F 160
160
447.3 In view of above, it was decided to seek compliance with documentary evidence.
449.2 It was noted that inspection report has pointed out the following huge deficiencies -
a) Principal & teaching staff is not appointed.
b) it was not clear as to whether the building shown to inspectors was for pharmacy or
for any other course. Except building nothing was there.
c) as per inspectors’ remarks, institution was not interested in inspection.
d) equipments as per ER-91 were not available.
449.3 In view of above, it was decided to reject the application for 2017-2018 academic
session.
451.3 In view of above, it was decided to reject the application for 2017-2018 academic
session.
F 162
162
453.3 In view of above, it was decided to seek compliance with documentary evidence.
454.2 It was noted that institution is not interested in approval of D.Pharm course from 2017-
2018 academic session. In view of it, it was decided to reject the application for 2017-
2018 academic session.
455.3 In view of above, it was decided to seek compliance with documentary evidence.
461.2 It was noted that institution is not interested in approval of D.Pharm course from 2017-
2018 academic session. In view of it, it was decided to reject the application for 2017-
2018.
464.3 In view of above, it was decided to reject the application for 2017-2018 academic
session.
Otherdecision
- It was noted that 8 excess admissions made by institution during 2012-2013 academic session stands
neutralized during 2015-2016 academic session. In view of it, it was decided to regularize the 8
excess admissions made by the institution during 2012-2013 academic session and inspect for
considering further extension of approval.
F 168
168
470.2 On telephonic enquiry during the course of EC meeting on Mobile Nos. given in SDF in
respect of -
a) Shri Hari Raghuram Desu - not responding.
b) Shri Naga Rai Kiran T. - informed that he has not completed his Ph.D.
c) the Mobile No.08647219898 given in respect of Shri Kommana Balaram Kumar, did
not belong to him.
470.3 In view of above, it was decided to seek clarification in the matter.
471.2 It was noted that compliance is signed by the Chairman and not the Principal.
471.3 In view of above, it was decided to call the Principal to appear before the PHC of PCI
with all records with regard to teaching staff.
01.101.475: Approval of the Degree course and examination in Pharmacy conducted at St.
Mary’s Pharmacy College, Deshmukhi Village, Pochampally Mandal, Nalgonda
Distt. Hyderabad (Telangana), in the light of 3rd Surprise Inspection Report
(September, 2015).
---------------------------------------------------------------------------------------------------
(32-771/2015(C)-PCI)
475.1 The latest information on record including representation dt.15.12.2016 received from the
institution was placed.
475.2 It was decided to ask the institution to submit the lists for 60 students each for the
academic sessions 2008-2009 to 2011-2012 and of 100 students each for the academic
sessions 2012-2013 to 2016-2017 for which the institution wants approval for registration
of students as pharmacists. The lists should be duly certified by the Examining Authority
and countersigned by the student concerned.
01.101.477: Approval of the Degree course and examination in Pharmacy conducted at Adarsh
College of Pharmacy Bhavaninagar Kundal Road, Tal- khanpur Dist-Sangli
(Maharashtra), in the light of 3rd Inspection Report (June, 2016).
---------------------------------------------------------------------------------------------------
(32-1127/2017-PCI)
477.2 It was noted that institution is already approved upto 2016-2017 academic session for 60
admissions.
477.3 It was decided to neutralize 44 excess admissions made during 2014-2015 & 2015-2016
academic session as per following details -
Session Excess Admns. to be
admission to made
be neutralized
*2017-2018 15 45
*2018-2019 15 45
*2019-2020 14 46
* if approval is extended by the PCI.
479.2 It was decided to approve the change of the Examining Authority in respect of following
institutions for various pharmacy courses -
a) B R Nahata College of Pharmacy, Mandsaur, Madhya Pradesh.
b) Mandsaur Institute of Pharmacy, Rewas Dewda Road Near MIT Campus, Mandsaur -
458001, Madhya Pradesh.
From To
Rajiv Gandhi Proudyogiki Mandsaur University
Vishwavidyalaya Bypass Square
Airport, Byepass Road, Rewas Dewda Road
Gandhi Nagar, SH-31,
Bhopal – 462 036. Mandsaur – 458 001.
480.3 In view of above, it was decided to insist for compliance with documentary evidence.
Allow 60
admissions for
2017-2018 in 1st
year
Otherdecision
- It was further decided to seek compliance particularly regarding appointment of teaching staff as
prescribed under the “The Bachelor of Pharmacy (B.Pharm) Course Regulations, 2014” and
“Minimum Qualification for Teachers in Pharmacy Institutions Regulations, 2014”.
F 173
173
01.101.483: Approval of the Degree course and examination in Pharmacy conducted at L.B.
Institute of Pharmaceutical Education & Research Sh. B.D. Rao College Campus,
Bethak Road, Khambhat – 388 620, Distt. Anand (Gujarat), in the light of 6th
Inspection Report (January, 2017).
---------------------------------------------------------------------------------------------------
(32-884/2015-PCI)
483.1 The latest information on record was placed.
483.3 In view of above, it was decided to seek compliance with documentary evidence.
485.2 It was decided to call the old Principal and current Principal alongwith Management to
appear before the PHC of PCI for verification of the complaint.
488.2 It was noted that institution has not replied to Council’s letter dt.22.1.2017.
488.3 In view of above, it was decided to close the file. However, institution may apply afresh.
491.2 It was noted that inspection report has pointed out the following huge deficiencies -
a) faculty for Pharm.D. (PB) is appointed but they do not have teaching experience.
b) faculty ratio of Professor to Associate Professor to Assistant Professor shall be
maintained as per norms.
F 177
177
491.3 In view of above, it was decided to reject the application for Pharm.D. (PB) course.
491.4 It was further decided to seek clarification from inspectors as to why they did not submit
point-wise reply to Council’s following points as specifically mentioned in deputation
letter -
a) whether full teaching faculty is available as per the “Minimum Qualification for
Teachers in Pharmacy Institutions Regulations, 2014” and Pharm.D. Regulations,
2008.
b) number of teachers appointed exclusively for Pharm.D. course.
c) number of teachers with M.Pharm (Practice) / Pharm.D. qualification.
d) subscription of DIC software / database.
e) establishment of DIC in hospital.
f) training of teaching staff with Pharmaceutics / Pharmacology qualification in
Pharmacy Practice.
5. Drug Regulatory 15
Affairs
6. Pharmaceutical 15
Biotechnology
7. Pharmacy Practice 15
8. Pharmacology 15
9. Pharmacognosy 15
10. Pharmaceutical 15
Administration
11. Pharmaceutical 15
Marketing
Otherdecision
- Regarding Pharmaceutical Marketing & Pharmaceutical Administration, it was noted that
the nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall
justify the nomenclature with course content for consideration of approval under Appendix-A of
M.Pharm Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
- Considering the inspection report (Dec., 2016), the decision of 100th CC (Nov.,2016) was
reviewed and approval was granted as above.
F 180
180
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 181
181
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
4. Pharmaceutical 12
Chemistry
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 185
185
5. Pharmaceutical 3
Management &
Regulatory
Affairs
6. Pharmacognosy 6
Otherdecision
- Regarding Quality Assurance and Pharmaceutical Management & Regulatory Affairs, it was
noted that the nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution
shall justify the nomenclature with course content for consideration of approval under Appendix-A
of M.Pharm Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
F 187
187
4. Pharmaceutical 3
Chemistry
532.2 It was noted that Dr. Rajendra Singh is working as full time Professor in Jamia Salafiyya
Pharmacy College, Malappuram, Kerala. It was learnt during the EC meeting that Dr.
Rajendra Singh is also working as Principal in Tirupur Kalaimagal College of Pharmacy,
Tirupur, Tamil Nadu.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 189
189
537.2 It was decided to instruct the institution to submit the teaching staff details in Council’s
prescribed format.
Otherdecision (60-711/2016-PCI)
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
- It was further decided to approve the change in the name of the institution as per following
details -
From To
Shree Krishna Institute of Ratnamani College of
Pharmacy Pharmacy
Krishna Campus, Ratnamani Education
Shankhalpur Campus, Shankhalpur
Ta-Bechraji, Ta-Becharaji, Road to-
Distt. Mehsana – 384 210 Becharaji
(North Gujarat) Distt. Mehsana – 384 210
5. Pharmacy Practice 5
Otherdecision
- Considering the inspection report (Dec., 2016), the decision of 100th CC (Nov.,2016) was reviewed
and approval was granted as above.
F 192
192
3. Quality Assurance 15
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
546.2 It was decided to instruct the institution to submit the teaching staff details in Council’s
prescribed format.
547.2 It was decided to instruct the institution to submit the teaching staff details in Council’s
prescribed format.
Otherdecision
- Regarding Pharmaceutical Regulatory Affairs, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
555.2 It was decided to instruct the institution to submit the teaching staff details in Council’s
prescribed format.
e) many faculty members have not submitted the experience certificates and relieving
orders.
f) some signature of faculty embers does not match with signature in old SIF submitted
to PCI.
g) Form 16 is not issued.
h) many students were absent during the inspection.
i) some equipments are deficient.
j) many equipments & machines are not working properly.
k) Payscales are not implemented as per norms.
l) library books are very less and needs more books for reference.
m) journals should be procured.
556.3 In view of above, it was decided to seek compliance of deficiencies pointed out in
inspection report (Nov., 2016) with documentary evidence.
556.4 It was further decided to instruct the institution to submit the teaching staff details in
Council’s prescribed format.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- It was noted that 275th EC (March, 2017) recommended approval. The institution submitted
representation, considering which the decision of 275th EC (March, 2017) was reiterated as above.
F 198
198
5. Drug Regulatory 12
Affairs
6. Quality Assurance 12
Otherdecision
- Regarding Drug Regulaotry Affairs and Quality Assurance, it was noted that the
nomenclature is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the
nomenclature with course content for consideration of approval under Appendix-A of M.Pharm
Regulations or align the nomenclature with prescribed nomenclatures under M.Pharm
Regulations.
- It was noted that 275th EC (March, 2017) recommended approval. The institution submitted
representation, considering which the above decision was taken.
F 199
199
Otherdecision
- Regarding Quality Assurance Techniques, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
563.2 It was decided to instruct the institution to submit the teaching staff details in Council’s
prescribed format.
F 200
200
Otherdecision
- Regarding Drug Regulaotry Affairs, it was noted that the nomenclature is not as per Appendix-
A of M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
4. Pharmacognosy 9
5. Pharmacology 6
Otherdecision
- Regarding Drug Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-
A of M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
568.2 It was decided to instruct the institution to submit the teaching staff details in Council’s
prescribed format.
Otherdecision
- Considering the inspection report (Jan.,2017), the decision of 100th CC (Nov.,2016) was reviewed
and approval was granted as above.
F 203
203
4. Pharmaceutics 15
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance and Pharmaceutical Management
& Regulatory Affairs, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration
of approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
- It was noted that 275th EC (March, 2017) recommended approval. The recommendations were
reviewed and above decision was taken.
572.2 It was decided to instruct the institution to submit the teaching staff details in Council’s
prescribed format.
4. Pharmacognosy 15
Otherdecision
- Regarding Quality Assurance, it was noted that the nomenclature is not as per Appendix-A of
M.Pharm Regulations, hence institution shall justify the nomenclature with course content for
consideration of approval under Appendix-A of M.Pharm Regulations or align the nomenclature
with prescribed nomenclatures under M.Pharm Regulations.
F 205
205
4. Pharmaceutics 12
5. Hospital & 15
Clinical Pharmacy
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, Pharmaceutical Management &
Regulatory Affairs, Quality Assurance & Pharma Regulaotry Affairs and Hospital &
Clinical Pharmacy, it was noted that the nomenclature is not as per Appendix-A of M.Pharm
Regulations, hence institution shall justify the nomenclature with course content for consideration
of approval under Appendix-A of M.Pharm Regulations or align the nomenclature with prescribed
nomenclatures under M.Pharm Regulations.
Otherdecision
- Regarding Pharmaceutical Analysis & Quality Assurance, it was noted that the nomenclature
is not as per Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature
with course content for consideration of approval under Appendix-A of M.Pharm Regulations or
align the nomenclature with prescribed nomenclatures under M.Pharm Regulations.
F 206
206
582.2 It was decided to instruct the institution to submit the teaching staff details in Council’s
prescribed proforma for the following specializations -
1. Pharmaceutics
2. Pharmaceutical Chemistry
3. Pharmaceutical Quality Assurance
Otherdecision
- Regarding Quality Assurance Technique, it was noted that the nomenclature is not as per
Appendix-A of M.Pharm Regulations, hence institution shall justify the nomenclature with course
content for consideration of approval under Appendix-A of M.Pharm Regulations or align the
nomenclature with prescribed nomenclatures under M.Pharm Regulations.
- Considering the inspection report (Aug.,2016), the decision of 100th CC (Nov.,2016) was
reviewed and approval was granted as above.
598.4 It was further decided to take action in anticipation of comments from the Central
Council members on the minutes.
Otherdecision
- It was further decided to take action in anticipation of approval of the minutes from the Hon’ble
President.
The Registrar
Degree 32-1258/2016-PCI 60 For 2017-2018 Dr. M.G.R. Educational
Faculty of Pharmacy, for conduct of 1st and Research Institute
IR No.1st Dr. M.G.R. Educational year University
Surprise and Research Institute subject to appointment
Maduravoyal,
(Feb.,2017) University of Principal and
teaching staff and Chennai – 600 095.
Velappanchavadi, submission of SDF for
Chennai – 600077. the same.
Prc/01.101 website